Login / Signup

Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study.

Sung-Wook ParkTae Jun KimJune Young LeeEun Ran KimSung Noh HongDong Kyung ChangMi YangSeonwoo KimMyung-Hee ShinYoung-Ho Kim
Published in: Alimentary pharmacology & therapeutics (2018)
The incidence of immune-mediated diseases in IBD patients was higher than that of non-IBD population. 5-ASA use may reduce this risk.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • peritoneal dialysis
  • risk factors
  • prognostic factors
  • patient reported outcomes